BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36417106)

  • 1. An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
    Yamakawa T; Ishigami K; Ohwada S; Kazama T; Hirayama D; Yoshii S; Yamano HO; Nakase H
    Clin J Gastroenterol; 2023 Apr; 16(2):187-192. PubMed ID: 36417106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
    Alhalabi M; Eddin KA; Ali F; Abbas A
    Medicine (Baltimore); 2022 Jan; 101(4):e28722. PubMed ID: 35089243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
    Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
    Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
    BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
    Dorofeyev AE; Rassokhina OA; Dorofeyeva AA
    Dig Dis; 2017; 35(1-2):45-49. PubMed ID: 28147350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.
    Filippi J; Laharie D; Michiels C; Flamand M; Bouguen G; Nancey S; Presles E; Paul S; Schneider S; Hébuterne X; Roblin X
    J Crohns Colitis; 2015 Mar; 9(3):252-8. PubMed ID: 25588386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem.
    Protic M; Markovic S; Tarabar D
    Dig Dis; 2017; 35(1-2):134-138. PubMed ID: 28147377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report.
    Bekić D; Belošić Halle Ž
    Croat Med J; 2021 Dec; 62(6):634-637. PubMed ID: 34981697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcerative colitis complicated by pyoderma gangrenosum and multiple aseptic abscesses].
    Kita A; Hashimoto Y; Sato K; Itoi Y; Kasuga K; Tanaka H; Hosaka H; Kuribayashi S; Uraoka T
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(11):1014-1021. PubMed ID: 36351620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.
    Cucchiara S; Romeo E; Viola F; Cottone M; Fontana M; Lombardi G; Rutigliano V; de'Angelis GL; Federici T
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S260-4. PubMed ID: 18598998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of a simple ulcer associated with ulcerative colitis that demonstrated a good clinical response to infliximab].
    Kishi M; Sou S; Ishihara H; Terabe H; Yasaka M; Kuhara K; Takeda T; Shimokoube M; Morimitsu Y; Miyazono K
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1682-8. PubMed ID: 26346358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy.
    Schnell A; Schwarz B; Wahlbuhl M; Allabauer I; Hess M; Weber S; Werner F; Schmidt H; Rechenauer T; Siebenlist G; Kaspar S; Ehrsam C; Rieger D; Rückel A; Metzler M; Christoph J; Woelfle J; Rascher W; Hoerning A
    Inflamm Bowel Dis; 2021 Jan; 27(2):224-235. PubMed ID: 32185399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
    Muñoz Villafranca C; Bravo Rodríguez MT; Ortiz de Zárate J; Arreba González P; García Kamiruaga I; Heras Martín JI; Cabezudo Gil P; Orive Cura V
    Gastroenterol Hepatol; 2016; 39(7):442-8. PubMed ID: 26948837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.
    Halpin SJ; Hamlin PJ; Greer DP; Warren L; Ford AC
    World J Gastroenterol; 2013 Feb; 19(7):1091-7. PubMed ID: 23467174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital pseudotumour as a presentation of paediatric ulcerative colitis.
    Tan JH; Chu HP; Das L; Arkachaisri T
    Singapore Med J; 2014 Oct; 55(10):e169-71. PubMed ID: 25631907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease.
    Meredith J; Khedim CA; Henderson P; Wilson DC; Russell RK
    J Crohns Colitis; 2021 Apr; 15(4):687-691. PubMed ID: 32997749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission.
    Viazis N; Pontas C; Manolakis A; Karampekos G; Tsoukali E; Galanopoulos M; Koustenis K; Archavlis E; Christidou A; Gazouli M; Mantzaris GJ
    Acta Gastroenterol Belg; 2021; 84(3):423-428. PubMed ID: 34599566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.